POSTNATAL TARGETING OF STRIATAL OPIOID & NMDA RECEPTORS
产后纹状体阿片类药物的靶向
基本信息
- 批准号:6294550
- 负责人:
- 金额:$ 21.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from the applicant's Description) The targeting of
opioid receptors, as well as their coordinated interactions with
N-methyl-D-aspartate subtype of glutamate receptors (NMDARs), is crucial for
normal brain development and motor functions involving patch-matrix
compartments in the mammalian caudate-putamen nucleus (CPN). During the
critical developmental plasticity period, mu and delta opioid receptors (MOR,
DOR) play either complementary or opposite roles that may in part involve
functional interaction with NMDAR. The goal of this application is to test
the hypothesis that there are age-related differences in the subcellular
localization of MOR and/or DOR, which are correlated with synaptogenesis and
parallel those of NMDAR in the CPN. The specific aims in each of the three
proposed studies will be pursued by examining the localization of sequence
specific antipeptide antisera against MOR, DOR, or NMDAR in the rat CPN during
postnatal ontogeny. The results obtained from these studies will complement
and extend previous knowledge that age-dependent MOR and DOR subcellular
distributions are functionally linked to neuronal maturation; that developing
NMDAR is largely involved in activity-dependent synaptic plasticity and has a
subcellular distribution that parallels the distribution of opioid receptors;
and that prenatal opioid availability differentially controls the ontogeny of
neurons containing opioid and/or glutamate receptors. Understanding opioid
and NMDA receptor targeting during development in the rat model may provide
information leading to new approaches for reactivation of developmental
plasticity in human brain.
描述:(改编自申请人的描述)目标是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HONG WANG其他文献
HONG WANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HONG WANG', 18)}}的其他基金
Roles of PS1 in y-secretase integrity and trafficking
PS1 在 y-分泌酶完整性和运输中的作用
- 批准号:
7018506 - 财政年份:2005
- 资助金额:
$ 21.19万 - 项目类别:
Roles of PS1 in y-secretase integrity and trafficking
PS1 在 y-分泌酶完整性和运输中的作用
- 批准号:
6885146 - 财政年份:2005
- 资助金额:
$ 21.19万 - 项目类别:
Roles of PS1 in y-secretase integrity and trafficking
PS1 在 y-分泌酶完整性和运输中的作用
- 批准号:
7220648 - 财政年份:2005
- 资助金额:
$ 21.19万 - 项目类别:
POSTNATAL TARGETING OF STRIATAL OPIOID & NMDA RECEPTORS
产后纹状体阿片类药物的靶向
- 批准号:
6619540 - 财政年份:2000
- 资助金额:
$ 21.19万 - 项目类别:
POSTNATAL TARGETING OF STRIATAL OPIOID & NMDA RECEPTORS
产后纹状体阿片类药物的靶向
- 批准号:
6379150 - 财政年份:2000
- 资助金额:
$ 21.19万 - 项目类别:
POSTNATAL TARGETING OF STRIATAL OPIOID & NMDA RECEPTORS
产后纹状体阿片类药物的靶向
- 批准号:
6798712 - 财政年份:2000
- 资助金额:
$ 21.19万 - 项目类别:
POSTNATAL TARGETING OF STRIATAL OPIOID & NMDA RECEPTORS
产后纹状体阿片类药物的靶向
- 批准号:
6523327 - 财政年份:2000
- 资助金额:
$ 21.19万 - 项目类别:
SPATIAL UNDERSAMPLING AND UNCERTAINTY IN AMBLYOPIA
弱视的空间欠采样和不确定性
- 批准号:
2160598 - 财政年份:1996
- 资助金额:
$ 21.19万 - 项目类别:
SPATIAL UNDERSAMPLING AND UNCERTAINTY IN AMBLYOPIA
弱视的空间欠采样和不确定性
- 批准号:
2160597 - 财政年份:1995
- 资助金额:
$ 21.19万 - 项目类别:
SPATIAL UNDERSAMPLING AND UNCERTAINTY IN AMBLYOPIA
弱视的空间欠采样和不确定性
- 批准号:
2160596 - 财政年份:1994
- 资助金额:
$ 21.19万 - 项目类别:














{{item.name}}会员




